KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Archives of pharmacal research

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12272-001-1182-9PMID 18449506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardioprotective effects of bms-180448, a prototype mitokatp channel opener, and the role of salvage kinases, in the rat model of global ischemia and reperfusion heart injury

  2007cited by this paper
• Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.

  2006cited by this paper
• SUR2A C‐terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes

  2004cited by this paper
• Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart.

  2004cited by this paper
• Exogenous activation of δ- and κ-opioid receptors affords cardioprotection in isolated murine heart

  2003cited by this paper
• Mitochondrial ATP-Sensitive Potassium Channel Activation Protects Cerebellar Granule Neurons From Apoptosis Induced by Oxidative Stress

  2003cited by this paper
• Pharmacological characterization of vasorelaxant effects of BMS-180448, a novel cardioselective ATP-sensitive potassium channel opener, in rat aorta.

  2003cited by this paper
• M‐LDH serves as a sarcolemmal KATP channel subunit essential for cell protection against ischemia

  2002cited by this paper
• Dynamic Sensitivity of ATP-sensitive K+Channels to ATP*

  2001cited by this paper
• Differential action of KR‐31378, a novel potassium channel activator, on cardioprotective and hemodynamic effects

  2001cited by this paper
• Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

  2001cited by this paper
• Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.

  2001cited by this paper
• Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning.

  2000cited by this paper
• Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.

  1999cited by this paper
• Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?

  1998cited by this paper
• Effect of timing of treatment of the glyburide-reversible cardioprotective activity of BMS-180448.

  1997cited by this paper
• In swine myocardium, the infarct size reduction induced by U-89232 is glibenclamide sensitive: evidence that U-89232 is a cardioselective opener of ATP-sensitive potassium channels.

  1997cited by this paper
• Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.

  1997cited by this paper
• Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.

  1996cited by this paper
• Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.

  1995cited by this paper
• Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil.

  1995cited by this paper
• Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.

  1995cited by this paper
• Pharmacology and Structure‐Activity Relationships for KATP Modulators: Tissue‐Selective KATP Openers

  1994cited by this paper
• The ATP‐Dependent Potassium Channel: An Endogenous Cardioprotective Mechanism

  1994cited by this paper
• Preconditioning the human myocardium.

  1993cited by this paper
• Cardioselective anti-ischemic ATP-sensitive potassium channel openers.

  1993cited by this paper
• Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids.

  1992cited by this paper
• Ischaemic preconditioning limits infarct size in the rat heart.

  1992cited by this paper
• ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.

  1991cited by this paper
• Lactic Dehydrogenase Activity in Blood.∗

  1955cited by this paper

• KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

  2023cites this paper
• Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels

  2020cites this paper
• Role of KATP channels in angiogenesis

  2015cites this paper
• Alpha lipoic acid protects the heart against myocardial post ischemia-reperfusion arrhythmias via K_ATP channel activation in isolated rat hearts

  2014cites this paper
• Effect of exercise and chronic administration of nandrolone decanoate on expression of rat heart sarcolemmal ATP- sensitive potassium channels

  2012cites this paper
• Sarcolemmal KATP channel modulators and cardiac arrhythmias.

  2011cites this paper
• KR-31761, a novel K+(ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K+(ATP) and Sarcolemmal K+(ATP) channels in rat models of ischemia/reperfusion-induced heart injury.

  2009cites this paper